Beverley Hammond

Improving the in Vitro Prediction of in Vivo Central Nervous System Penetration: Integrating Permeability, P-glycoprotein Efflux, and Free Fractions in Blood and Brain

Scott Summerfield, Alexander J. Stevens, Leanne Cutler et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 176 citations

The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2

Josie A. Blackie, Jackie C. Bloomer, Murray J. B. Brown et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 129 citations · Full text

Lipoprotein-associated Phospholipase A2, Biochemistry, Potent Inhibitor +8

Effects of the selective 5-HT7 receptor antagonist SB-269970 in animal models of psychosis and cognition

Kerry A. Waters, Tania O. Stean, Beverley Hammond et al. · Behavioural Brain Research · 2011 · 58 citations

Psychiatry, Psychotic Disorder, Medicine +10

3,4-Dihydro-2H-benzoxazinones are 5-HT1A receptor antagonists with potent 5-HT reuptake inhibitory activity

Peter J. Atkinson, Steven M. Bromidge, Mark Duxon et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 55 citations · Full text

Molecular Pharmacology, Biochemistry, Functional Selectivity +8

The discovery of 6-[2-(5-chloro-2-{[(2,4-difluorophenyl)methyl]oxy}phenyl)-1-cyclopenten-1-yl]-2-pyridinecarboxylic acid, GW848687X, a potent and selective prostaglandin EP1 receptor antagonist for the treatment of inflammatory pain

Gerard M.P. Giblin, Rino A. Bit, Susan H. Brown et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 47 citations · Full text

Inflammation, Medicinal Chemistry, Anti-inflammatory +13